Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The American Journal of Geriatric Pharmacotherapy
|
January 9, 2008
Incontinence related to management of benign prostatic hypertrophy
Euna Han, Libby K Black, John P Lavelle
Neurourology and Urodynamics
|
November 18, 2014
Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine
Jeongok Park, John P Lavelle, Mary H Palmer
BJU International
|
March 18, 2006
An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia
Rachael L DiSantostefano, Andrea K Biddle, John P Lavelle
Urology
|
November 16, 2005
Rare cause of ureteral obstruction
Kris E Gaston, Don A Gabriel, John P Lavelle
Pharmacoeconomics
|
February 8, 2006
The long-term cost effectiveness of treatments for benign prostatic hyperplasia
Rachael L DiSantostefano, Andrea K Biddle, John P Lavelle
Reviews in Urology
|
September 21, 2006
The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy
Matthew O Fraser, John P Lavelle, Michael S Sacks, et al.
Urology
|
September 6, 2005
Plasma cell (Zoon's) balanitis with concomitant HIV infection
Edward R Houser, Kris E Gaston, William K Funkhouser, et al.
The American Journal of Medicine
|
February 18, 2006
Management of incontinence for family practice physicians
John P Lavelle, Mickey Karram, Franklin M Chu, et al.
Urology
|
March 18, 2003
Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity
Yao-Chi Chuang, Michael B Chancellor, Satoshi Seki, et al.
American Journal of Physiology. Renal Physiology
|
November 12, 2002
Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis
Anthony J Kanai, Mark L Zeidel, John P Lavelle, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The American Journal of Geriatric Pharmacotherapy
|
January 9, 2008
Incontinence related to management of benign prostatic hypertrophy
Euna Han, Libby K Black, John P Lavelle
Neurourology and Urodynamics
|
November 18, 2014
Voiding dysfunction in older women with overactive bladder symptoms: A comparison of urodynamic parameters between women with normal and elevated post-void residual urine
Jeongok Park, John P Lavelle, Mary H Palmer
BJU International
|
March 18, 2006
An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia
Rachael L DiSantostefano, Andrea K Biddle, John P Lavelle
Urology
|
November 16, 2005
Rare cause of ureteral obstruction
Kris E Gaston, Don A Gabriel, John P Lavelle
Pharmacoeconomics
|
February 8, 2006
The long-term cost effectiveness of treatments for benign prostatic hyperplasia
Rachael L DiSantostefano, Andrea K Biddle, John P Lavelle
Reviews in Urology
|
September 21, 2006
The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy
Matthew O Fraser, John P Lavelle, Michael S Sacks, et al.
Urology
|
September 6, 2005
Plasma cell (Zoon's) balanitis with concomitant HIV infection
Edward R Houser, Kris E Gaston, William K Funkhouser, et al.
The American Journal of Medicine
|
February 18, 2006
Management of incontinence for family practice physicians
John P Lavelle, Mickey Karram, Franklin M Chu, et al.
Urology
|
March 18, 2003
Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity
Yao-Chi Chuang, Michael B Chancellor, Satoshi Seki, et al.
American Journal of Physiology. Renal Physiology
|
November 12, 2002
Manganese superoxide dismutase gene therapy protects against irradiation-induced cystitis
Anthony J Kanai, Mark L Zeidel, John P Lavelle, et al.
Page
of 1